Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Support RheumPAC to Keep Rheumatology in Healthcare Policy Conversations

From the College  |  February 3, 2024

The ACR thanks all members who contributed to RheumPAC in 2023. As we look forward to 2024 and Congress continues to debate healthcare policy, continued support is critical.

RheumPAC is the only political action committee dedicated to the interests of the rheumatology profession. Every dollar raised for RheumPAC goes directly to the re-election campaigns of our legislative champions to ensure that the lawmakers who best understand our issues remain in Congress. RheumPAC is also an educational tool that allows us to inform lawmakers and their staff about the issues rheumatologists and rheumatology professionals face daily.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

2024 is an election year, which means it is more critical than ever that RheumPAC is well equipped to support campaigns and take part in important healthcare discussions on Capitol Hill, such as the debate surrounding cuts to Medicare payments. Consider helping us start 2024 off strong by contributing to RheumPAC today!

Thank you again to everyone who contributed to RheumPAC in 2023. Your support has been and will continue to be critical to the success of the ACR’s advocacy efforts. If you have trouble accessing the contribution page, are unsure how much you have given this year or have any other questions, don’t hesitate to reach out to Paige Colston, manager of PAC & grassroots engagement.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Contributions to RheumPAC are used for political purposes and are not tax deductible for federal income tax purposes. All contributions to RheumPAC are voluntary and must be made with personal funds. You may refuse to contribute without reprisal. Any proposed contribution amounts are merely suggestions; you may choose to contribute more, less, or not at all. RheumPAC will not favor or disadvantage anyone by reason of the amount contributed or the decision not to contribute. Federal law prohibits contributions from corporations. RheumPAC participants must be U.S. citizens or permanent resident aliens.

Share: 

Filed under:Legislation & Advocacy Tagged with:RheumPAC

Related Articles

    I RheumPAC, Do You?

    September 1, 2009

    For many years, the ACR board of directors and Government Affairs Committee have done exemplary work in keeping members abreast of legislative regulatory issues that affect all aspects of rheumatology, including patient and physician/healthcare professional issues, education, and research. Through advocacy, the ACR advances rheumatology and fosters excellence in the care of people with, or at risk for, arthritis and rheumatic and musculoskeletal diseases. One might say that advocacy is a cornerstone of this organization.

    Advancing the ACR’s Legislative Priorities in 2021

    January 11, 2021

    With a new Congress and many new legislators in key leadership positions, your support today will help RheumPAC start the year off strong.

    A Huge Thank You to 251 People

    March 18, 2011

    RheumPAC supporters are helping to advance rheumatology

    RheumPAC: A Wise Investment to Let Your Voice Be Heard in Washington, D.C.

    April 5, 2021

    ACR/ARP members share why they support the ACR’s nonpartisan political action committee and see it as an investment in the future of rheumatology.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences